WEST PHARMACEUTICAL SERVICES INC (WST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 1.5B 3B 4.5B Q3 '21: 2.7B Q4 '21: 2.8B Q1 '22: 2.9B Q2 '22: 2.9B Q3 '22: 2.9B Q4 '22: 2.9B Q1 '23: 2.9B Q2 '23: 2.9B Q3 '23: 2.9B Q4 '23: 2.9B Q1 '24: 2.9B Q2 '24: 2.9B Q3 '24: 2.9B Q4 '24: 2.9B Q1 '25: 2.9B Q2 '25: 3B Q3 '25: 3B Q4 '25: 3.1B Q1 '26: 3.2B Q2 '26: 3.3B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 500M 1B 1.5B Q3 '21: 1.1B Q4 '21: 1.2B Q1 '22: 1.2B Q2 '22: 1.2B Q3 '22: 1.2B Q4 '22: 1.1B Q1 '23: 1.1B Q2 '23: 1.1B Q3 '23: 1.1B Q4 '23: 1.1B Q1 '24: 1.1B Q2 '24: 1B Q3 '24: 1B Q4 '24: 998.5M Q1 '25: 1B Q2 '25: 1B Q3 '25: 1.1B Q4 '25: 1.1B Q1 '26: 1.2B Q2 '26: 1.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

0 300M 600M 900M Q3 '21: 684.4M Q4 '21: 752.3M Q1 '22: 766.4M Q2 '22: 783.5M Q3 '22: 788.3M Q4 '22: 734M Q1 '23: 699.6M Q2 '23: 653.7M Q3 '23: 644.8M Q4 '23: 676M Q1 '24: 643.5M Q2 '24: 587.2M Q3 '24: 571.2M Q4 '24: 569.9M Q1 '25: 554.1M Q2 '25: 581.6M Q3 '25: 587.9M Q4 '25: 584.9M Q1 '26: 655M Q2 '26: 680.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

0 250M 500M 750M Q3 '21: 612.5M Q4 '21: 661.8M Q1 '22: 684.4M Q2 '22: 685.6M Q3 '22: 630.6M Q4 '22: 585.9M Q1 '23: 552.1M Q2 '23: 518.7M Q3 '23: 559.4M Q4 '23: 593.4M Q1 '24: 568.7M Q2 '24: 524.9M Q3 '24: 499.6M Q4 '24: 492.7M Q1 '25: 467.2M Q2 '25: 487.7M Q3 '25: 491.7M Q4 '25: 493.7M Q1 '26: 542.7M Q2 '26: 564.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 800M 1.6B 2.4B Q3 '21: 1.6B Q4 '21: 1.7B Q1 '22: 1.7B Q2 '22: 1.7B Q3 '22: 1.7B Q4 '22: 1.8B Q1 '23: 1.8B Q2 '23: 1.8B Q3 '23: 1.8B Q4 '23: 1.8B Q1 '24: 1.8B Q2 '24: 1.9B Q3 '24: 1.9B Q4 '24: 1.9B Q1 '25: 1.9B Q2 '25: 1.9B Q3 '25: 1.9B Q4 '25: 2B Q1 '26: 2.1B Q2 '26: 2.1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

0 300M 600M 900M Q3 '21: 571.9M Q4 '21: 584M Q1 '22: 646.5M Q2 '22: 675.2M Q3 '22: 654M Q4 '22: 724M Q1 '23: 710.9M Q2 '23: 707M Q3 '23: 768.2M Q4 '23: 776.5M Q1 '24: 756.6M Q2 '24: 752.4M Q3 '24: 702.4M Q4 '24: 653.4M Q1 '25: 664.6M Q2 '25: 676.7M Q3 '25: 693.8M Q4 '25: 754.8M Q1 '26: 715.3M Q2 '26: 662.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

0 200M 400M 600M Q3 '21: 337.3M Q4 '21: 330.6M Q1 '22: 382M Q2 '22: 401.5M Q3 '22: 387.8M Q4 '22: 439.4M Q1 '23: 410M Q2 '23: 396.8M Q3 '23: 420M Q4 '23: 414.5M Q1 '24: 386.1M Q2 '24: 357.1M Q3 '24: 321.6M Q4 '24: 276.4M Q1 '25: 306.9M Q2 '25: 344M Q3 '25: 379.1M Q4 '25: 468.9M Q1 '26: 458M Q2 '26: 436.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '20: 75.5M Q2 '20: 75.5M Q3 '20: 75.8M Q1 '21: 75.8M Q2 '21: 75.7M Q3 '21: 76M Q1 '22: 76M Q2 '22: 75.8M Q3 '22: 75.7M Q1 '23: 75.7M Q2 '23: 75.4M Q3 '23: 75.3M Q1 '24: 74.3M Q2 '24: 73.7M Q3 '24: 73.4M Q1 '25: 73M Q2 '25: 72.5M Q3 '25: 72.6M Q1 '26: 72.4M Q2 '26: 71.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.50 7.00 10.50 Q3 '21: 8.06 Q4 '21: 8.66 Q1 '22: 8.96 Q2 '22: 8.97 Q3 '22: 8.25 Q4 '22: 7.73 Q1 '23: 7.29 Q2 '23: 6.87 Q3 '23: 7.42 Q4 '23: 7.88 Q1 '24: 7.58 Q2 '24: 7.03 Q3 '24: 6.74 Q4 '24: 6.69 Q1 '25: 6.37 Q2 '25: 6.68 Q3 '25: 6.75 Q4 '25: 6.79 Q1 '26: 7.48 Q2 '26: 7.81 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.